Plain-English translation of NCT06633120 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new laboratory technique called in vitro maturation (IVM) that helps mature eggs outside the body before fertilization. Instead of using high-dose hormone stimulation like traditional fertility treatment, this method uses lower doses of medication, retrieves immature eggs, and matures them overnight in the lab. The mature eggs are then fertilized and grown into embryos for transfer.
Many women with polycystic ovary syndrome or other fertility challenges struggle with traditional fertility treatments because of how their bodies respond to high-dose hormones. This trial exists to see if the new treatment—which uses gentler, lower-dose stimulation—can be just as effective while potentially reducing side effects and costs for patients.
You likely qualify if…
You likely don't qualify if…
You will start with a complete fertility evaluation to make sure you qualify. Then you'll receive 3 days of low-dose hormone medications, followed by an ultrasound-guided procedure to retrieve your immature eggs. Your eggs will be matured overnight in the laboratory, fertilized the next day, and grown for several days. Your embryos will be biopsied and tested for genetic health, and the trial covers the cost of testing the first 14 embryos. You'll then prepare for your first frozen embryo transfer, with some medication and testing covered through your first pregnancy test.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
United States